Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Diagnostic stewardship of C. difficile testing: a quasi-experimental antimicrobial stewardship study.

Christensen AB, Barr VO, Martin DW, Anderson MM, Gibson AK, Hoff BM, Sutton SH, Widmaier V, Salim AA, Silkaitis C, Qi C, Zembower TR, Postelnick MJ, Rhodes NJ.

Infect Control Hosp Epidemiol. 2019 Mar;40(3):269-275. doi: 10.1017/ice.2018.336. Epub 2019 Feb 21.

PMID:
30786942
2.

Vancomycin Area Under the Curve and Acute Kidney Injury: A Meta-analysis.

Aljefri DM, Avedissian SN, Rhodes NJ, Postelnick MJ, Nguyen K, Scheetz MH.

Clin Infect Dis. 2019 Nov 13;69(11):1881-1887. doi: 10.1093/cid/ciz051.

3.

Understanding the Components, Calculation, and Impact of Monthly and Seasonal Variation of the Standardized Antimicrobial Utilization Ratio (SAAR).

Avedissian SN, Rhodes NJ, Liu J, Aljefri D, Postelnick MJ, Sutton SH, Zembower TR, Martin D, Pais G, Cruce CE, Scheetz MH.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e01780-18. doi: 10.1128/AAC.01780-18. Print 2019 Mar.

4.

Measuring the impact of varying denominator definitions on standardized antibiotic consumption rates: implications for antimicrobial stewardship programmes.

Avedissian SN, Scheetz MH, Zembower TR, Silkaitis C, Maxwell R, Jenkins C, Postelnick MJ, Sutton SH, Rhodes NJ.

J Antimicrob Chemother. 2018 Oct 1;73(10):2876-2882. doi: 10.1093/jac/dky275.

PMID:
30085084
5.

Implementation of a cefazolin-based stewardship pathway for methicillin-susceptible Staphylococcus aureus bloodstream infections paired with infectious diseases consultation.

Lee BJ, Rao SN, Wang SK, Lee JY, Lakada IY, Gilbert EM, Barr VO, Postelnick MJ, Sutton SH, Zembower TR, Bolon M, Scheetz MH, Rhodes NJ.

Int J Antimicrob Agents. 2017 May;49(5):650-654. doi: 10.1016/j.ijantimicag.2016.12.021. Epub 2017 Mar 6.

PMID:
28279787
6.

Prediction of inventory sustainability during a drug shortage.

Rhodes NJ, Gilbert EM, Skoglund E, Esterly JS, Postelnick MJ, McLaughlin MM.

Am J Health Syst Pharm. 2016 Jul 15;73(14):1094-8. doi: 10.2146/ajhp150532.

PMID:
27385704
7.

Impact of vancomycin treatment duration and dose on kidney injury.

Bosch K, McLaughlin MM, Esterly JS, Rhodes NJ, Postelnick MJ, Scheetz MH.

Int J Antimicrob Agents. 2014 Mar;43(3):297-8. doi: 10.1016/j.ijantimicag.2013.11.004. Epub 2013 Dec 7. No abstract available.

PMID:
24388114
8.

Clinical implications of antiretroviral drug interactions with warfarin: a case-control study.

Esterly JS, Darin KM, Gerzenshtein L, Othman F, Postelnick MJ, Scarsi KK.

J Antimicrob Chemother. 2013 Jun;68(6):1360-3. doi: 10.1093/jac/dkt043. Epub 2013 Feb 20.

PMID:
23425779
9.

An analysis of the accuracy of physician-entered indications on computerized antimicrobial orders.

Patel JA, Esterly JS, Scheetz MH, Postelnick MJ.

Infect Control Hosp Epidemiol. 2012 Oct;33(10):1066-7. doi: 10.1086/667746. No abstract available.

PMID:
22961035
10.

Effective use of a clinical decision-support system to advance antimicrobial stewardship.

Patel J, Esterly JS, Scheetz MH, Bolon MK, Postelnick MJ.

Am J Health Syst Pharm. 2012 Sep 15;69(18):1543-4. doi: 10.2146/ajhp110729. No abstract available.

PMID:
22935933
11.

Successful treatment of extensively drug-resistant Acinetobacter baumannii peritoneal dialysis peritonitis with intraperitoneal polymyxin B and ampicillin-sulbactam.

Fitzpatrick MA, Esterly JS, Postelnick MJ, Sutton SH.

Ann Pharmacother. 2012 Jul-Aug;46(7-8):e17. doi: 10.1345/aph.1R086. Epub 2012 Jul 17.

PMID:
22811349
12.

Evaluation of clinical outcomes in patients with bloodstream infections due to Gram-negative bacteria according to carbapenem MIC stratification.

Esterly JS, Wagner J, McLaughlin MM, Postelnick MJ, Qi C, Scheetz MH.

Antimicrob Agents Chemother. 2012 Sep;56(9):4885-90. doi: 10.1128/AAC.06365-11. Epub 2012 Jul 9.

13.

Prospective approach to managing antimicrobial drug shortages.

Griffith MM, Patel JA, Sutton SH, Bolon MK, Esterly JS, Gross AE, Postelnick MJ, Zembower TR, Scheetz MH.

Infect Control Hosp Epidemiol. 2012 Jul;33(7):745-52. doi: 10.1086/666332. Epub 2012 May 18. Review.

PMID:
22669238
14.

The impact of anti-infective drug shortages on hospitals in the United States: trends and causes.

Griffith MM, Gross AE, Sutton SH, Bolon MK, Esterly JS, Patel JA, Postelnick MJ, Zembower TR, Scheetz MH.

Clin Infect Dis. 2012 Mar 1;54(5):684-91. doi: 10.1093/cid/cir954. Epub 2012 Jan 19.

PMID:
22267747
15.

Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections.

Esterly JS, Griffith M, Qi C, Malczynski M, Postelnick MJ, Scheetz MH.

Antimicrob Agents Chemother. 2011 Oct;55(10):4844-9. doi: 10.1128/AAC.01728-10. Epub 2011 Aug 8.

16.

Low incidence of renal impairment observed in tenofovir-treated patients.

O'Donnell EP, Scarsi KK, Darin KM, Gerzenshtein L, Postelnick MJ, Palella FJ Jr.

J Antimicrob Chemother. 2011 May;66(5):1120-6. doi: 10.1093/jac/dkr039. Epub 2011 Feb 17.

PMID:
21393145
17.

Differences in clinical outcomes in patients with vancomycin-resistant enterococci according to linezolid susceptibility.

Scheetz MH, Knechtel SA, Postelnick MJ, Malczynski M, Qi C.

Pharmacotherapy. 2010 Dec;30(12):1221-8. doi: 10.1592/phco.30.12.1221.

PMID:
21114389
18.

Risk factors for aminoglycoside ototoxicity in adult cystic fibrosis patients.

O'Donnell EP, Scarsi KK, Scheetz MH, Postelnick MJ, Cullina J, Jain M.

Int J Antimicrob Agents. 2010 Jul;36(1):94-5. doi: 10.1016/j.ijantimicag.2010.02.018. Epub 2010 Apr 10. No abstract available.

PMID:
20382508
19.

Empiric antibiotic selection for infectious emergencies: bacterial pneumonia, meningitis and sepsis.

O'Donnell EP, Hurt KM, Scheetz MH, Postelnick MJ, Scarsi KK.

Drugs Today (Barc). 2009 May;45(5):379-93. doi: 10.1358/dot.2009.45.5.1371116. Review.

PMID:
19584966
20.

Effect of differences in MIC values on clinical outcomes in patients with bloodstream infections caused by gram-negative organisms treated with levofloxacin.

Defife R, Scheetz MH, Feinglass JM, Postelnick MJ, Scarsi KK.

Antimicrob Agents Chemother. 2009 Mar;53(3):1074-9. doi: 10.1128/AAC.00580-08. Epub 2008 Dec 15.

21.

Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption.

Scheetz MH, Knechtel SA, Malczynski M, Postelnick MJ, Qi C.

Antimicrob Agents Chemother. 2008 Jun;52(6):2256-9. doi: 10.1128/AAC.00070-08. Epub 2008 Apr 7.

22.

Serum piperacillin/tazobactam pharmacokinetics in a morbidly obese individual.

Newman D, Scheetz MH, Adeyemi OA, Montevecchi M, Nicolau DP, Noskin GA, Postelnick MJ.

Ann Pharmacother. 2007 Oct;41(10):1734-9. Epub 2007 Aug 28.

PMID:
17726066
23.

In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.

Scheetz MH, Qi C, Warren JR, Postelnick MJ, Zembower T, Obias A, Noskin GA.

Antimicrob Agents Chemother. 2007 May;51(5):1621-6. Epub 2007 Feb 16.

24.

Peritoneal fluid penetration of tigecycline.

Scheetz MH, Reddy P, Nicolau DP, Noskin GA, Postelnick MJ, Stosor V, Zembower TR.

Ann Pharmacother. 2006 Nov;40(11):2064-7. Epub 2006 Oct 17.

PMID:
17047138
25.

Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay.

Scarsi KK, Feinglass JM, Scheetz MH, Postelnick MJ, Bolon MK, Noskin GA.

Antimicrob Agents Chemother. 2006 Oct;50(10):3355-60.

26.

The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.

Scheetz MH, Qi C, Noskin GA, Warren JR, Postelnick MJ, Malczynski M, Huang J, Zembower TR.

Diagn Microbiol Infect Dis. 2006 Dec;56(4):407-13. Epub 2006 Aug 23.

PMID:
16930924
27.

Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia.

Scheetz MH, Wunderink RG, Postelnick MJ, Noskin GA.

Pharmacotherapy. 2006 Apr;26(4):539-50. Review.

PMID:
16553514
28.

Adjustment of antimicrobial dosages for continuous venovenous hemofiltration based on patient-specific information.

Scheetz MH, Scarsi KK, Ghossein C, Hurt KM, Zembower TR, Postelnick MJ.

Clin Infect Dis. 2006 Feb 1;42(3):436-7; author reply 437-8. No abstract available.

PMID:
16392098
30.

Effect of on-call infectious-diseases pharmacists on antibiotic expenditures.

Scheetz MH, Postelnick MJ, Scarsi KK, Gerzenshtein L, Bolon MK, Fotis M, Noskin GA.

Am J Health Syst Pharm. 2005 Oct 1;62(19):1967-8. No abstract available.

PMID:
16174825
31.

Breakthrough Candida infections in patients receiving voriconazole.

Gerzenshtein L, Patel SM, Scarsi KK, Postelnick MJ, Flaherty JP.

Ann Pharmacother. 2005 Jul-Aug;39(7-8):1342-5. Epub 2005 May 24.

PMID:
15914520
32.

Lack of effect of fluoroquinolone resistance on mortality in subjects with Pseudomonas aeruginosa bacteraemia.

Scheetz MH, Bolon MK, Scarsi KK, Fotis MA, Postelnick MJ.

J Infect. 2006 Feb;52(2):105-10.

PMID:
15904961
33.

The impact of gender and pregnancy on antiretroviral therapy for HIV: pharmacokinetic and disease-related differences.

Scarsi KK, Postelnick MJ.

J Gend Specif Med. 2003;6(1):7-16. Review. No abstract available.

PMID:
12661172
34.

The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance.

Lee CE, Zembower TR, Fotis MA, Postelnick MJ, Greenberger PA, Peterson LR, Noskin GA.

Arch Intern Med. 2000 Oct 9;160(18):2819-22.

PMID:
11025792
35.

Synergistic effect of gentamicin plus ampicillin on enterococci with differing sensitivity to gentamicin: a phenotypic assessment of NCCLS guidelines.

Dressel DC, Tornatore-Reuscher MA, Boschman CR, Stosor V, Zembower T, Postelnick MJ, Noskin GA, Peterson LR.

Diagn Microbiol Infect Dis. 1999 Nov;35(3):219-25.

PMID:
10626133
36.

The utility of aminoglycosides in an era of emerging drug resistance.

Zembower TR, Noskin GA, Postelnick MJ, Nguyen C, Peterson LR.

Int J Antimicrob Agents. 1998 May;10(2):95-105. Review.

PMID:
9716286
37.

Survey of vancomycin monitoring guidelines in Illinois hospitals.

Fitzsimmons WE, Postelnick MJ, Tortorice PV.

Drug Intell Clin Pharm. 1988 Jul-Aug;22(7-8):598-600.

PMID:
3416749
38.

Rapid adjustment of theophylline: a kinetic model.

Postelnick MJ, Lesher CA, Steiner VI, Nitti JR, Springborn PW, Jaresko GS.

Drug Intell Clin Pharm. 1984 Jun;18(6):519-22.

PMID:
6734437
39.

Computer program for individual flow-rate charts for i.v. medications.

Lesher CA, Postelnick MJ, Springborn PW.

Am J Hosp Pharm. 1984 May;41(5):948-9. No abstract available.

PMID:
6547272

Supplemental Content

Loading ...
Support Center